Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction

Cardiovascular complications are the most prevalent cause of morbidity and mortality in diabetic patients. Metformin is currently the first-line blood glucose-lowering agent with potential relevance to cardiovascular diseases. However, the underpinning mechanisms of action remain elusive. Here, we r...

Descripción completa

Detalles Bibliográficos
Autores principales: Loi, Halyna, Boal, Frederic, Tronchere, Helene, Cinato, Mathieu, Kramar, Solomiia, Oleshchuk, Oleksandra, Korda, Mykhaylo, Kunduzova, Oksana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400884/
https://www.ncbi.nlm.nih.gov/pubmed/30873028
http://dx.doi.org/10.3389/fphar.2019.00154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400884/
https://www.ncbi.nlm.nih.gov/pubmed/30873028
http://dx.doi.org/10.3389/fphar.2019.00154

Ejemplares similares